Lung transplant infection study aims to improve Long-Term survival

NCT ID NCT00177918

Completed Knowledge-focused Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 600 lung transplant recipients at the University of Pittsburgh to see how common viral and bacterial infections are and how they affect long-term health. Researchers focused on whether a specific infection (C. pneumoniae) is linked to a condition called bronchiolitis obliterans, which can damage the lungs. The goal is to better understand infections after transplant to improve patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help doctors better predict and manage infections after lung transplants, potentially improving long-term survival.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove that controlling infections will improve outcomes, and results may not apply to all transplant centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans bronchiolitis obliterans syndrome disease related to transplantation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHIOLITIS OBLITERANS DISORDER RELATED TO LUNG TRANSPLANTATION

Contacts and locations

Locations

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.